Budzisz E, Nawrot E, Malecka M
Institute of Chemistry, Faculty of Pharmacy, Medical University of Lodz, 90-151 Lodz, Muszynskiego 1, Poland.
Arch Pharm (Weinheim). 2001 Dec;334(12):381-7. doi: 10.1002/1521-4184(200112)334:12<381::AID-ARDP381>3.0.CO;2-0.
Dimethyl 2,6-dimethyl-4-oxo-4H-chromen-3-yl-phosphonate (1a) and dimethyl 6-methyl-2-phenyl-4-oxo-4H-chromen-3-yl-phosphonate (1b) were synthesized and reacted with primary aliphatic amines to yield title compounds 4-6. Their antibacterial properties against Gram-positive and Gram-negative bacteria strains were tested by the MIC method. Four of seventeen tested compounds (1d, 3, 4a, and 4b) exhibit detectable activity against S. aureus. Some representative examples of newly synthesized compounds were tested for their alkylating properties in vitro in the Preussmann test. Compounds 1a, 1c, 1d, 3, 5d, and 6a possess highly alkylating activity toward standard derivative 4-(4'-nitrobenzyl)pyridine (NBP).
合成了2,6 - 二甲基 - 4 - 氧代 - 4H - 色烯 - 3 - 基膦酸二甲酯(1a)和6 - 甲基 - 2 - 苯基 - 4 - 氧代 - 4H - 色烯 - 3 - 基膦酸二甲酯(1b),并使其与伯脂肪胺反应生成标题化合物4 - 6。通过MIC法测试了它们对革兰氏阳性和革兰氏阴性细菌菌株的抗菌性能。在测试的17种化合物中,有4种(1d、3、4a和4b)对金黄色葡萄球菌表现出可检测到的活性。在普雷斯曼试验中,对一些新合成化合物的体外烷基化性能进行了测试。化合物1a、1c、1d、3、5d和6a对标准衍生物4 -(4'-硝基苄基)吡啶(NBP)具有高度烷基化活性。